These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20678017)

  • 21. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 77 C/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link.
    Vogel A; Strassburg CP; Manns MP
    Genes Immun; 2003 Jan; 4(1):79-81. PubMed ID: 12595907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MyD88-dependent pathway accelerates the liver damage of Concanavalin A-induced hepatitis.
    Ojiro K; Ebinuma H; Nakamoto N; Wakabayashi K; Mikami Y; Ono Y; Po-Sung C; Usui S; Umeda R; Takaishi H; Yamagishi Y; Saito H; Kanai T; Hibi T
    Biochem Biophys Res Commun; 2010 Sep; 399(4):744-9. PubMed ID: 20696131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune hepatitis: are we using the right therapy?
    Murray KF
    J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):18-9. PubMed ID: 17204947
    [No Abstract]   [Full Text] [Related]  

  • 25. [Genetic risk factors for hepatic fibrosis in chronic liver diseases].
    Wasmuth HE; Lammert F; Matern S
    Med Klin (Munich); 2003 Dec; 98(12):754-62. PubMed ID: 14685677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adaptive immunity in autoimmune hepatitis.
    Longhi MS; Ma Y; Mieli-Vergani G; Vergani D
    Dig Dis; 2010; 28(1):63-9. PubMed ID: 20460892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Autoimmune hepatitis. Physiopathologic, clinical, histological, and therapeutic features].
    Duclos-Vallée JC; Johanet C; Sebagh M; Samuel D; Yamamoto AM
    Ann Med Interne (Paris); 2001 Oct; 152(6):371-82. PubMed ID: 11907950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA interference targeting Fas protects mice from fulminant hepatitis.
    Song E; Lee SK; Wang J; Ince N; Ouyang N; Min J; Chen J; Shankar P; Lieberman J
    Nat Med; 2003 Mar; 9(3):347-51. PubMed ID: 12579197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic diseases--hitting the target with inhibitory RNAs.
    Davidson BL
    N Engl J Med; 2003 Dec; 349(24):2357-9. PubMed ID: 14668464
    [No Abstract]   [Full Text] [Related]  

  • 30. Disease- and cell-specific expression of GP73 in human liver disease.
    Iftikhar R; Kladney RD; Havlioglu N; Schmitt-Gräff A; Gusmirovic I; Solomon H; Luxon BA; Bacon BR; Fimmel CJ
    Am J Gastroenterol; 2004 Jun; 99(6):1087-95. PubMed ID: 15180730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment challenges and investigational opportunities in autoimmune hepatitis.
    Czaja AJ; Bianchi FB; Carpenter HA; Krawitt EL; Lohse AW; Manns MP; McFarlane IG; Mieli-Vergani G; Toda G; Vergani D; Vierling J; Zeniya M
    Hepatology; 2005 Jan; 41(1):207-15. PubMed ID: 15690485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current therapy for autoimmune hepatitis.
    Montano Loza AJ; Czaja AJ
    Nat Clin Pract Gastroenterol Hepatol; 2007 Apr; 4(4):202-14. PubMed ID: 17404588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immune response to hepatitis B virus proteins: relevance of the murine model.
    Milich DR
    Semin Liver Dis; 1991 May; 11(2):93-112. PubMed ID: 1832237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis.
    Czaja AJ
    Curr Pharm Des; 2011; 17(29):3120-40. PubMed ID: 21902661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Infections and autoimmune diseases.
    Bach JF
    J Autoimmun; 2005; 25 Suppl():74-80. PubMed ID: 16278064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Marked changes of the hepatic sinusoid in a transgenic mouse model of acute immune-mediated hepatitis.
    Warren A; Bertolino P; Benseler V; Fraser R; McCaughan GW; Le Couteur DG
    J Hepatol; 2007 Feb; 46(2):239-46. PubMed ID: 17125874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of autoimmune hepatitis.
    Vergani D; Mieli-Vergani G
    Pediatr Transplant; 2004 Dec; 8(6):589-93. PubMed ID: 15598331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Favorable outcomes of autoimmune hepatitis in a community clinic setting.
    Seo S; Toutounjian R; Conrad A; Blatt L; Tong MJ
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1410-4. PubMed ID: 18373564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Animal models of autoimmune liver disease.
    Peters MG
    Immunol Cell Biol; 2002 Feb; 80(1):113-6. PubMed ID: 11869369
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.